Archive for April, 2007
Tell me about your career
I’ve been asked quite a bit recently to talk about my career path. I usually begin my talks by explaining that I don’t think my path is anything to draw best practices from, and add that many of the key opportunities I was able to benefit from are no longer available, but then I encourage [...]
Update on the price control power struggle
I previously posted how price controls and compulsory licensing give buyers more power … for a price and Abbott’s spat with Thailand, where they threatened to stop offering any new drugs in the country as a reaction to price controls.
The latest developments, however, show that pharma companies do not have the upper hand. Abbott’s CEO [...]
Biotech 360
Coming soon, a new biotechnology magazine from The Scientist called Biotech 360. I’ve been asked to compile a list of the top biotechnology blogs. Want to know who made the cut? You’ll have to wait until May 10th.
Abbott Gets Tough with Thailand
In response to Thailand’s decision to issue compulsory licenses for Kaletra and for Plavix, effectively bypassing their patents by purchasing generic versions from India, Abbott has responded by redusing to launch any new drugs in Thailand.
As I discussed in an earlier post, price controls and compulsory licensing give buyers more power … for a price. [...]
Carnival of Biotechnology
Welcome to the April 10, 2007 edition of Carnival of Biotechnology.
Finance and business development
On Pharma presents a report that tens of thousands of pharma sales reps are suing current and former employers for overtime - $1 billion in settlements could be at stake.
H.S. Ayoub presents The Biotech Industry: 30 Years of Failure posted [...]
Upcoming Events
I’ll be giving a talk at UC Davis from April 19-20th and UNC Chapel Hill from May 16-17th. If you’re in the area and would like to meet up, drop me a line
